Table 2. Percent of cells in different phase of cell cycle at different time interval in treated (DOX: Doxorubicin, PATA: Paclitaxel, SLCA B, SLCA C) and untreated (CNT-Control) cells.

Time	Treatment	G0	G1	S	G2	M
6 h	CNT	0	34.91±3.95	48.42±0.08	8.22±4.67	8.45±0.81
	DOX	3.28±1.26	8.87±0.04	20.27±3.17	59.33±5.10	8.24±3.15
	PATA	2.05±1.97	9.12±0.86	11.57±2.28	51.39±3.78	25.86±2.60
	SLCA C	8.47±2.20	51.67±0.55	32.06±0.83	6.66±0.72	1.13±0.10
	SLCA B	0.52±0.21	56.21±4.99	33.81±3.58	6.55±0.23	2.89±1.38
12h	CNT	4.97±0.00	7.13±0.30	6.86±0.02	6.88±0.11	74.15±0.16
	DOX	54.92±3.59	37.34±0.76	2.37±0.03	5.54±2.45	2.82±2.37
	PATA	1.78±0.14	9.46±0.33	14.52±2.01	45.73±3.92	28.50±1.73
	SLCA C	4.21±3.90	54.33±2.02	32.72±0.90	7.7±0.62	1.03±0.35
	SLCA B	2.71±1.54	52.30±0.60	31.71±2.40	9.31±1.31	3.96±3.24
18h	CNT	1.63±0.35	4.68±0.01	4.66±0.01	4.74±0.10	84.29±0.25
	DOX	54.70±2.44	34.98±0.91	2.69±0.51	4.91±0.61	2.71±2.23
	PATA	2.43±0.33	10.85±1.15	12.02±1.82	52.21±2.52	22.47±0.12
	SLCA C	3.49±0.15	55.33±2.20	31.14±3.04	9.17±1.91	0.86±0.92
	SLCA B	5.69±5.28	53.21±1.68	32.27±0.88	7.50±2.61	1.32±0.11
24h	CNT	1.565±0.35	2.02±0.25	5.34±0.62	2.32±0.02	88.74±0.49
	DOX	54.70±3.20	35.61±4.55	3.03±1.35	4.01±4.03	2.63±2.37
	PATA	0.29±0.28	15.55±1.28	7.10±1.21	52.87±2.55	24.17±2.34
	SLCA C	0.17±0.25	55.24±0.21	35.52±0.80	8.60±0.35	0.45±0.49
	SLCA B	0.09±0.00	53.94±2.01	27.45±1.71	16.99±4.43	1.52±0.71

The darkened numbers indicate the percentage of cells arrested in different phases of cell cycle.

The data is mean ± SD of three independent experiments.